Compile Data Set for Download or QSAR
Report error Found 46 Enz. Inhib. hit(s) with all data for entry = 11163
TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596373(2-(ethyl(2-ethyl-7-fluoro-5-(4-(2-(3-hydroxyazetid...)
Affinity DataIC50: 11nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596360(2-(ethyl(2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-...)
Affinity DataIC50: 12nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596353(2-(ethyl(2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-...)
Affinity DataIC50: 20nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596372(US11591342, Compound S-0134A)
Affinity DataIC50: 20nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596354(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 23nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596365(2-(ethyl(2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-...)
Affinity DataIC50: 24nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM50322724(3-[(4-{[3-(4-Fluorobenzyl)-2,4-dioxo-1,3-thiazolan...)
Affinity DataIC50: 24nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596363(2-(ethyl(2-ethyl-7-fluoro-5-(4-(2-(3-hydroxyazetid...)
Affinity DataIC50: 25nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596377(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 27nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596357(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 31nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596364(4-(3,4-difluorophenyl)-2-(ethyl(2-ethyl-7-fluoro-5...)
Affinity DataIC50: 32nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596349((R)-2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2...)
Affinity DataIC50: 36nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596371(2-((2-ethyl-7-fluoro-5-(4-(2-(3-hydroxyazetidin-1-...)
Affinity DataIC50: 36nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596337(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 39nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596346(2-(ethyl(2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-...)
Affinity DataIC50: 40nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596361(2-((2-ethyl-5-(4-(2-(3-hydroxy-3-methylazetidin-1-...)
Affinity DataIC50: 41nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596376(2-((2,2-difluoroethyl)(2-ethyl-5-(4-(2-(3-hydroxya...)
Affinity DataIC50: 43nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596348(2-(ethyl(2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-...)
Affinity DataIC50: 43nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596350((S)-2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2...)
Affinity DataIC50: 46nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596370(US11591342, Compound S-0131A)
Affinity DataIC50: 47nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596359(US11591342, Compound S-0105CP)
Affinity DataIC50: 49nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596362(4-(3,4-difluorophenyl)-2-((2-ethyl-5-(4-(2-(3-hydr...)
Affinity DataIC50: 61nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596335(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 62nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596332(2-((2-ethyl-7-fluoro-5-(4-(2-(3-hydroxyazetidin-1-...)
Affinity DataIC50: 88nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596352((S)-2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2...)
Affinity DataIC50: 88nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596367(2-((2-cyclopropyl-7-fluoro-5-(4-(2-(3-hydroxyazeti...)
Affinity DataIC50: 100nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596330(US11591342, Compound S-0021)
Affinity DataIC50: 102nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596347(4-(3,4-difluorophenyl)-2-((2-ethyl-5-(4-(2-(3-hydr...)
Affinity DataIC50: 107nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596355(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 119nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596374((R)-2-(ethyl(2-ethyl-7-fluoro-5-(4-(2-(3-hydroxyaz...)
Affinity DataIC50: 132nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596368(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 142nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596356(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 160nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596334(4-(3,4-difluorophenyl)-2-((2-ethyl-7-fluoro-5-(4-(...)
Affinity DataIC50: 165nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596366(2-((7-fluoro-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-ox...)
Affinity DataIC50: 178nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596331(2-((2-ethyl-7-fluoro-5-(4-(2-(3-hydroxyazetidin-1-...)
Affinity DataIC50: 188nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596351((R)-2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2...)
Affinity DataIC50: 207nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM50187686(CHEMBL3828074 | US9670204, 2 2-((2-ethyl-6-(4-(2-(...)
Affinity DataIC50: 245nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596358(US11591342, Compound S-0104CP)
Affinity DataIC50: 256nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596340(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 261nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596369(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 264nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596375(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 325nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596345(6-((2-ethyl-7-fluoro-5-(4-(2-(3-hydroxyazetidin-1-...)
Affinity DataIC50: 407nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596338(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 648nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596336(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 767nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596339(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 5.53E+3nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetAutotaxin(Human)
Suzhou Sinovent Pharmaceuticals

US Patent
LigandPNGBDBM596341(2-((2-ethyl-5-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxo...)
Affinity DataIC50: 1.00E+4nMAssay Description:Preparation and Treatment. Stock Solution Preparation. A 10 mM DMSO stock solution was formulated for each compound. A 30 mM DMSO stock solution was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent